FSD Pharma
Nathan Coyle joined FSD Pharma Inc in 2020 as Corporate Controller and was appointed to the Interim Chief Financial Officer role in 2021. Mr. Coyle has 15 years of executive business experience as a finance leader in both public and private roles. With a keen eye for analytical analysis and innovative ideas he has always led his team to success.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
FSD Pharma
FSD Pharma is committed to the pursuit of developing innovative novel biotechnologies to bring advanced neurodegenerative and mental health treatments to market.